Oxford BioMedica PLC (OXBDF)

[marcusl2]

For the benefit of anyone else George;
Listen from 3mins 80 and make your own mind up. OXB`s IP is worth a fortune. Look at the other company valuations. We get a % of CTL-019 and other Car-T, add that to everything else and put a PE on it. I am confident the value will rise significantly.

From John Dawson(7mins), "WE have undisclosed royalties on CTL019 and other CAR-t products. A small number on these royalties can be very spectacular "
Analysts predict that those could make $10 billion/yr. 1% for OXB is £32m pe of 8 = company valuation of £260m. Any success with the other drugs is additional money. He also say that further IP deals will be coming through.

The early-stage trial of CTL019 engineered cells conducted by researchers at the University of Pennsylvania indicates the potential of the complicated treatment, which analysts have estimated may generate $10 billion a year if its uses expand beyond leukemia. The therapy can provoke serious side affects, however, and eight of the 30 patients required intensive care for severe cytokine-release syndrome.